Worth reading
66In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
46000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 12th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Who receives how much
Number of shares delivered during the month: 46,000 shares (46,000 new shares; 0 treasury shares transferred)
EVO FUND (issued on 8 December 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
Existing Shares and Increase
+0.70%Rate of increase
9,314,419 shares9,360,419Shares
Exercise ratio subject to exercise restrictions: 0.7% (46,000 shares / 6,544,419 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the month covered were ¥150, ¥153 and ¥151. An exercise price adjustment clause applies. The minimum exercise price is ¥150.
Number of Stock Acquisition Rights
Total number issued: 60,000; number unexercised as of the end of the month preceding the month covered: 35,300; number unexercised as of the end of the month covered: 34,840
Basis for determining the amount to be paid
Exercise prices: ¥150 (minimum exercise price), ¥153 and ¥151. The periods for the closing price and average share price used as the basis for calculation, as well as the discount and premium rates, are Not disclosed.
Procedures under the Corporate Code of Conduct
The status of compliance with the exercise restrictions under Article 434 of the Listing Regulations is disclosed.
Most recent equity financing
8 December 2025: The 12th Series of Stock Acquisition Rights (with exercise price adjustment clause) was issued through a third-party allotment. Total number issued: 60,000.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 12th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 46,000 shares (46,000 new shares; 0 treasury shares transferred) |
| Intended allottee | EVO FUND (issued on 8 December 2025) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 0.7% (46,000 shares / 6,544,419 shares) |
| Total number of issued shares | 9,314,419 shares (as of the end of the month preceding the month covered) → 9,360,419 shares (number of shares after issuance, assuming that the number of treasury shares before issuance remains unchanged) |
| Basis for determining the amount to be paid | Exercise prices: ¥150 (minimum exercise price), ¥153 and ¥151. The periods for the closing price and average share price used as the basis for calculation, as well as the discount and premium rates, are Not disclosed. |
| Exercise price | Exercise prices during the month covered were ¥150, ¥153 and ¥151. An exercise price adjustment clause applies. The minimum exercise price is ¥150. |
| Number of Stock Acquisition Rights | Total number issued: 60,000; number unexercised as of the end of the month preceding the month covered: 35,300; number unexercised as of the end of the month covered: 34,840 |
| Procedures under the Corporate Code of Conduct | The status of compliance with the exercise restrictions under Article 434 of the Listing Regulations is disclosed. |
| Most recent equity financing | 8 December 2025: The 12th Series of Stock Acquisition Rights (with exercise price adjustment clause) was issued through a third-party allotment. Total number issued: 60,000. |
Items this document does not state (18)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.